Analystreport

Aerie Pharmaceuticals Inc (NASDAQ: AERI) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

Aerie Pharmaceuticals, Inc.  (AERI) 
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aeriepharma.com/investor-relations